Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback